Abstract
Electrical cardioversion (CV) of atrial fibrillation (AF) is associated with an increased risk of stroke, and its appropriate prevention is still a matter of debate. It is known that, besides dislodgement of pre-existing intra-atrial thrombi, the ‘stunned’ atrium after CV is an important cause of thrombus formation and subsequent embolism. We investigated whether CV of AF is associated with occurrence of circulating microemboli (ME) representing a sensitive marker of the actual thromboembolic activity. Twenty-nine patients (22 men) aged 54 ± 13 years suffering from valvular (n = 5) or nonvalvular (n = 24) AF were studied. All but 1 patient (with recent-onset AF) had been put on oral anticoagulation (INR >2.0) for at least 3 weeks before and 4 weeks after successful CV. In all patients, exclusion of internal carotid artery stenosis and atrial thrombus was performed prior to CV. Five unilateral 1-hour transcranial Doppler ME monitorings over the middle cerebral artery were performed (1) before CV, and (2) immediately, (3) 4–6 h, (4) 24 h, and (5) 2–4 weeks after CV. Total absence of circulating ME was found before CV as well as during a cumulative monitoring time of 115 h after successful CV. Electrical CV of AF after at least 3 weeks of effective anticoagulation is not associated with occurrence of cerebral circulating ME. This finding requires further investigation including high-risk patients with AF undergoing CV based on different treatment protocols.
References
1.
Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983–988.
2.
Cairns JA, Connolly SJ: Nonrheumatic atrial fibrillation: Risk of stroke and role of antithrombotic therapy. Circulation 1991;84:469–481.
3.
Pritchett EL: Management of atrial fibrillation. N Engl J Med 1992;326:1264–1271.
4.
Bjerkelund CJ, Orning OM: The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208–216.
5.
Mancini GBJ, Goldberger AL: Cardioversion of atrial fibrillation: Consideration of immobilisation, anticoagulation, prophylactic pacemaker, and long-term success. Am Heart J 1982;104:617–621.
6.
Goldmann MJ: The management of chronic atrial fibrillation: Indications for and method of conversion to sinus rhythm. Prog Cardiovasc Dis 1960;2:465–479.
7.
Collins LJ, Silverman DI, Douglas PS, Manning WJ: Cardioversion of nonrheumatic atrial fibrillation. Reduced thrombotic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995;92:156–159.
8.
Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG: Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996;93:1262–1277.
9.
Golzari H, Cebul RD, Bahler RC: Atrial fibrillation: Restoration and maintenance of sinus rhythm and indications for anticoagulant therapy. Ann Intern Med 1996;125:311–323.
10.
Manning WJ, Silverman DI, Gordon SPF, Krumholz MK, Douglas PS: Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750–755.
11.
Seto TB, Taira DA, Tsevat J, Manning WJ: Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: A decision analytic model for patients admitted to the hospital with atrial fibrillation. J Am Coll Cardiol 1997;29:122–130.
12.
Black IW, Fatkin D, Sagar KB, Khanderia BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C, et al: Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994;89:2509–2513.
13.
Fatkin D, Kuchar DL, Thorburn CW, Feneley MP: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for ‘stunning’ as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307–316.
14.
Stoddard MF, Dawkins PR, Prince CR, Longaker RA: Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995;129:1204–1215.
15.
Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS: Impaired left atrial mechanical function after cardioversion: Relationship to the duration of atrial fibrillation. J Am Coll Cardiol 1994;23:1535–1540.
16.
Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL: Impact of electric cardioversion for atrial fibrillation on left appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359–1366.
17.
Daniel WD: Should transesophageal echocardiography be used to guide cardioversion? N Engl J Med 1993;328:803–804.
18.
Gersh BJ, Gottdiener JS: Shadows on the wall: The role of transesophageal echocardiography in atrial fibrillation. Ann Intern Med 1995;123:882–884.
19.
Spencer MP: Detection of cerebral artery emboli; in Newell DW, Aaslid R (eds): Transcranial Doppler. New York, Raven Press, 1992, pp 216–230.
20.
Siebler M, Sitzer M, Rose G, Steinmetz H: Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995;26:2184–2186.
21.
Babikian VL, Wijman CAC, Hyde C, Cantelmo NL, Winter MR, Baker E, Pochay V: Cerebral microembolism and early recurrent cerebral or ischemic events. Stroke 1997;28:1314–1318.
22.
Sliwka U, Job FP, Wissuwa D, Diehl RR, Flachskampf FA, Hanrath P, Noth J: Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism. A prospective study. Stroke 1995;26:2067–2070.
23.
Infeld B, Bowser DN, Gerraty RP, et al: Cerebral microemboli in atrial fibrillation detected by transcranial Doppler ultrasonography. Cerebrovasc Dis 1996;6:339–345.
24.
Nabavi DG, Arato S, Droste DW, Schulte-Altedorneburg G, Kemény V, Reinecke H, Borggrefe M, Breithardt G, Ringelstein EB: Microembolic load in asymptomatic patients with cardiac aneurysm, severe ventricular dysfunction, and atrial fibrillation. Clinical and hemorheological correlates. Cerebrovasc Dis 1998;8:214–221.
25.
Nabavi DG, Georgiadis D, Mumme T, Schmid C, Zunker P, Scheld HH, Ringelstein EB: Clinical relevance intracranial microembolic signals in patients with left ventricular assist devices. Stroke 1996;27:891–896.
26.
Cullinane M, Wainwright R, Brown A, Monaghan M, Markus HS: Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants. A prospective study. Stroke 1998;29:1810–1815.
27.
Deklunder G, Roussel M, Lecroart JL, Prat A, Gautier C: Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves. Stroke 1998;29:1821–1826.
28.
Daffertshofer M, Ries S, Schminke U, Hennerici M: High-intensity transient signals in patients with cerebral ischemia. Stroke 1996;27:1844–1849.
29.
Molloy J, Markus HS: Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999;30:1440–1443.
30.
Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA: Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke 1991;22:253–258.
31.
Markus HS, Brown MM: Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model. Stroke 1993;24:1–5.
32.
Droste DW, Markus HS, Nassiri D, Brown MM: The effect of velocity on the appearance of embolic signals studied in transcranial Doppler models. Stroke 1994;25:986–991.
33.
Gaunt ME, Ratliff DA, Martin PJ, Smith JL, Bell PR, Naylor AR: On-table diagnosis of incipient carotid artery thrombosis during carotid endarterectomy by transcranial Doppler scanning. J Vasc Surg 1994;20:104–107.
34.
Georgiadis D, Goeke J, Hill M, König M, Nabavi DG, Stogbauer F, Zunker P, Ringelstein EB: A novel technique for identification of Doppler microembolic signals based on the coincidence method. Stroke 1996;27:683–686.
35.
Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium: Basic identification criteria of Doppler microembolic signals. Stroke 1995;26:1123.
36.
Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M: Consensus on microembolus detection by TCD. Stroke 1998;29:725–729.
37.
Nadareishvili ZG, Choudary Z, Joyner C, Brodie D, Norris J: Cerebral microembolism in acute myocardial infarction. Stroke 1999;30:2679–2681.
38.
Omran H, Jung W, Rabahieh R, Schimpf R, Wolpert C, Hagendorff A, Fehske W, Lüderitz B: Left atrial chamber and appendage function after internal atrial defibrillation: A prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 1997;29:131–138.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
